LABORATORY RESEARCH FLT3-ITD Knockin Impairs Hematopoietic Stem Cell Quiescence/Homeostasis, Leading to Myeloproliferative Neoplasm Expression of FMS-like tyrosine kinase-3 (FLT3)-internal tandem duplication (ITD) from the endogenous promoter in a murine knockin model results in progenitor expansion and a myeloproliferative neoplasm. In this study, the authors showed that this expansion begins with overproliferation within a compartment of normally quiescent long-term hematopoietic stem cells, which become rapidly depleted. [Cell Stem Cell] Abstract Temporal Changes in PTEN and mTORC2 Regulation of Hematopoietic Stem Cell Self-Renewal and Leukemia Suppression Researchers showed that Rictor deletion prevents leukemogenesis and hematopoietic stem cell depletion after Pten deletion in adult mice, implicating mTORC2 activation in these processes. [Cell Stem Cell] Abstract Cis-Element Mutated in GATA2-Dependent Immunodeficiency Governs Hematopoiesis and Vascular Integrity GATA2 encodes a master regulator of hematopoiesis that is also linked to endothelial biology. Though the disease-causing mutations commonly occur in the GATA-2 DNA binding domain, scientists identified a patient with mycobacterial infection and myelodysplasia who had an uncharacterized heterozygous deletion in a GATA2 cis-element consisting of an E-box and a GATA motif. [J Clin Invest] Full Article | Press Release PTH Expands Short-Term Murine Hemopoietic Stem Cells through T Cells Scientists showed that T cells are required for intermittent parathyroid hormone (iPTH) to expand short-term hemopoietic stem and progenitor cells and improve blood cell engraftment and host survival after bone marrow transplantation. [Blood] Abstract Targeting JAK1/2 and mTOR in Murine Xenograft Models of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia (ALL) Researchers investigated the efficacy of the JAK inhibitor ruxolitinib and the mTOR inhibitor rapamycin in xenograft models of eight pediatric B-precursor ALL cases with and without CRLF2 and JAK genomic lesions. [Blood] Abstract C/EBPβ Promotes BCR-ABL-Mediated Myeloid Expansion and Leukemic Stem Cell Exhaustion Investigators examined the role of C/EBPβ, a regulator for ′emergency granulopoiesis′, in the pathogenesis of the chronic phase of chronic myeloid leukemia. [Leukemia] Abstract Sorafenib Has Potent Anti-Tumor Activity in Multiple Myeloma In Vitro, Ex Vivo and In Vivo, in the 5T33MM Mouse Model Researchers demonstrated that sorafenib induces cell death in multiple myeloma (MM) cell lines and in CD138+ enriched primary MM patient samples in a caspase-dependent and independent manner. [Cancer Res] Abstract | Press Release Multifaceted Roles of PTEN and TSC Orchestrate Growth and Differentiation of Drosophila Blood Progenitors Investigators demonstrated that in the Drosophila lymph gland the tumor suppressors TSC and PTEN control blood progenitor proliferation through a common TOR- and 4EBP-dependent pathway. [Development] Abstract | Press Release CLINICAL RESEARCH Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia In childhood acute myeloid leukemia (AML), morphologic assessment of treatment response has limited value if minimal residual disease is measured by flow cytometry. MLL fusion transcripts can provide prognostic information in some patients, whereas monitoring of AML1-ETO and CBFβ-MYH11 transcripts is largely uninformative. [J Clin Oncol] Abstract | Press Release Age-Adjusted Recipient Pre-Transplant Telomere Length and Treatment-Related Mortality after Hematopoietic Stem Cell Transplantation Researchers concluded that age-adjusted recipients’ telomere length is an independent biological marker of treatment related mortality after hematopoietic stem cell transplantation. [Blood] Abstract |